Carevive Appoints Aaron Galaznik, M.D. as Chief Scientific Officer
Carevive announced today the appointment of Aaron Galaznik, M.D. as Chief Scientific Officer. In this new role, Dr. Galaznik will lead all scientific and clinical activities associated with Carevive, including its real-world evidence (RWE) and patient-reported outcomes (PRO) strategies.
CareviveFebruary 15, 2022







